ACAD
Acadia Pharmaceuticals Inc. · Healthcare
EVP and CFO Mark C. Schneyer sold $344K of Acadia Pharmaceuticals Inc.
Sold$344,475
$22.50Price
15,310Shares
−41%Stake
What ACAD did after the filing
- The stock from Mon, May 22 open, $24.32
- −0.4%
- S&P 500, same days
- +5.4%
Measured over 30 trading days, to the Jul 6 close.
Traded Wed, May 17. Filed Fri, May 19, 6:48 PM ET, after the close. Returns use the May 22 open and the Jul 6 close. Not investment advice.